Pierre Fabre Laboratories , Castres 81100 , France.
Neurolixis , Dana Point , California 92629 , United States.
ACS Chem Neurosci. 2019 Jul 17;10(7):3101-3107. doi: 10.1021/acschemneuro.8b00661. Epub 2019 Apr 2.
When placed in an unfamiliar and brightly lit open-field, two adult male rats that have not previously interacted display a low level of social interaction (SI) attributed to an anxiety-like state. The SI test has therefore been used to explore anxiolytic/antistress activity. Here, we investigated the effects of serotonin 5-HT receptor agonists displaying various activity profiles, i.e. partial vs full agonist efficacy and pre- versus postsynaptic 5-HT receptor preferential activation by "biased agonists". Adult male Sprague-Dawley rats were housed singly before starting the social interaction session. At 30 min before being placed in an open-field, both rats of the dyad were injected (i.p or s.c.) with either vehicle, diazepam (as a reference compound), or one of six 5-HT receptor agonists: NLX-101 (a.k.a. F15599), F13714, S15535, flesinoxan, 8-OH-DPAT, and buspirone. Time spent in SI (following, sniffing, playing) was recorded for 10 min. Time spent in SI was inversely correlated with light intensity, with values dropping nearly by half (212.6 ± 18.8 vs 113.7 ± 7.0 s) between 10 and 300 lx (measured at floor level). Under the high light intensity conditions (300 lx), diazepam showed a bell-shaped curve, significantly increasing SI (78% increase in interaction time above control) at 1 mg/kg i.p. only. In the case of 5-HT receptor ligands, full agonists, whether nonpreferential (flesinoxan, (±)8-OH-DPAT) or preferential for presynaptic receptors (F13714), showed the strongest activity in this model. The preferential presynaptic receptor partial agonist, S15535, was also active over a wide dose-range, although with lower efficacy than F13714. In contrast, NLX-101, a high-efficacy biased agonist that preferentially activates postsynaptic 5-HT receptors, exhibited little activity. The clinical anxiolytic, buspirone, showed a marked effect likely due to its partial agonist activity at 5-HT presynaptic receptors. These data support the hypothesis that enhancement of SI in this model is mediated by preferential agonist activation of presynaptic 5-HT receptors, and confirm previous studies using local microinjections of (±)8-OH-DPAT. They further support the utility of noninvasive administration of biased agonists for exploring the activity of 5-HT receptor subpopulations.
当两只从未相互作用过的成年雄性大鼠被放置在一个陌生且明亮的开阔场中时,它们表现出低水平的社交互动(SI),这归因于一种类似焦虑的状态。因此,SI 测试已被用于探索抗焦虑/抗应激活性。在这里,我们研究了具有不同活性谱的 5-羟色胺 5-HT 受体激动剂的作用,即部分激动剂与完全激动剂的功效以及前突触与后突触 5-HT 受体的优先激活,通过“偏向激动剂”。成年雄性 Sprague-Dawley 大鼠在开始社交互动之前单独饲养。在将对组合放置在开阔场之前 30 分钟,对组合中的两只大鼠分别(ip 或 sc)注射载体、地西泮(作为参考化合物)或六种 5-HT 受体激动剂之一:NLX-101(又名 F15599)、F13714、S15535、 flesinoxan、8-OH-DPAT 和丁螺环酮。记录 10 分钟的 SI 时间(跟随、嗅探、玩耍)。SI 时间与光强度呈负相关,在 10 和 300 lx(在地面水平测量)之间,值几乎下降了一半(212.6 ± 18.8 与 113.7 ± 7.0 s)。在高强度光(300 lx)条件下,地西泮呈钟形曲线,仅在 1 mg/kg ip 时显着增加 SI(与对照相比,互动时间增加 78%)。在 5-HT 受体配体的情况下,全激动剂,无论是非选择性的(flesinoxan、(±)8-OH-DPAT)还是优先作用于突触前受体(F13714),在该模型中表现出最强的活性。优先作用于突触前受体的部分激动剂 S15535 在较宽的剂量范围内也具有活性,尽管效力低于 F13714。相比之下,高效力的偏向激动剂 NLX-101 优先激活突触后 5-HT 受体,表现出很少的活性。临床抗焦虑药丁螺环酮表现出明显的作用,这可能是由于其对 5-HT 突触前受体的部分激动剂活性所致。这些数据支持这样的假设,即该模型中 SI 的增强是通过优先激活突触前 5-HT 受体的激动剂来介导的,并证实了先前使用(±)8-OH-DPAT 局部微注射的研究。它们进一步支持非侵入性给予偏向激动剂以探索 5-HT 受体亚群活性的实用性。